Luciana Tromba1, Francesco Tartaglia2, Sabino Carbotta1, Nadia Sforza1, Fabio Pelle1, Vanessa Colagiovanni3, Giovanni Carbotta4, Stefania Cavaiola5, Giovanni Casella1. 1. Surgical Sciences Department, "Sapienza" University of Rome, Rome, Italy. 2. Surgical Sciences Department, "Sapienza" University of Rome, Rome, Italy. francesco.tartaglia@uniroma1.it. 3. Gynecological, Obstetric Sciences Department and Urological Sciences, "Sapienza" University of Rome, Rome, Italy. 4. Department of Experimental Medicine, "Sapienza" University of Rome, Rome, Italy. 5. CNR, IBB, Rome, Italy.
Abstract
BACKGROUND: Obesity is an independent cardiovascular risk factor and a catalyst of other cardiovascular risk factors, such as hypertension, dyslipidemia, type 2 diabetes mellitus (DM2) and metabolic syndrome. METHODS: We analyzed cardiovascular risk in obese patients before and after sleeve gastrectomy (SG). To this end, we studied changes in body mass index (BMI), blood chemistry parameters that characterize the risk of atherosclerosis and instrumental parameters (objective markers of this risk), namely intima-media thickness (IMT) and flow-mediated dilation (FMD), the latter reflecting endothelial function. We also considered purely cardiac parameters-mitral annular plane systolic excursion (MAPSE) and tricuspid annular plane systolic excursion (TAPSE)-which describe cardiac risk more specifically than the ejection fraction. Alteration of one or more of these parameters determines an increase in cardiovascular morbidity and mortality. RESULTS: The results showed that weight loss, in patients undergoing SG, is accompanied by a reduced BMI and a marked improvement in blood chemistry, confirming what has already been shown in many other studies, but the most interesting finding was the effect of SG on the instrumental markers of atherosclerosis. In particular, carotid IMT was significantly reduced (p < 0.001) and FMD significantly improved. MAPSE and TAPSE also improved significantly at both follow-up assessments (p < 0.001). CONCLUSIONS: This study suggests that SG should be considered from a broader perspective, i.e. as a weight loss treatment that also improves obesity-related morbidity and mortality, benefitting both the patient and, in an economic sense, the society as a whole.
BACKGROUND:Obesity is an independent cardiovascular risk factor and a catalyst of other cardiovascular risk factors, such as hypertension, dyslipidemia, type 2 diabetes mellitus (DM2) and metabolic syndrome. METHODS: We analyzed cardiovascular risk in obesepatients before and after sleeve gastrectomy (SG). To this end, we studied changes in body mass index (BMI), blood chemistry parameters that characterize the risk of atherosclerosis and instrumental parameters (objective markers of this risk), namely intima-media thickness (IMT) and flow-mediated dilation (FMD), the latter reflecting endothelial function. We also considered purely cardiac parameters-mitral annular plane systolic excursion (MAPSE) and tricuspid annular plane systolic excursion (TAPSE)-which describe cardiac risk more specifically than the ejection fraction. Alteration of one or more of these parameters determines an increase in cardiovascular morbidity and mortality. RESULTS: The results showed that weight loss, in patients undergoing SG, is accompanied by a reduced BMI and a marked improvement in blood chemistry, confirming what has already been shown in many other studies, but the most interesting finding was the effect of SG on the instrumental markers of atherosclerosis. In particular, carotid IMT was significantly reduced (p < 0.001) and FMD significantly improved. MAPSE and TAPSE also improved significantly at both follow-up assessments (p < 0.001). CONCLUSIONS: This study suggests that SG should be considered from a broader perspective, i.e. as a weight loss treatment that also improves obesity-related morbidity and mortality, benefitting both the patient and, in an economic sense, the society as a whole.
Authors: John F Keaney; Martin G Larson; Ramachandran S Vasan; Peter W F Wilson; Izabella Lipinska; Diane Corey; Joseph M Massaro; Patrice Sutherland; Joseph A Vita; Emelia J Benjamin Journal: Arterioscler Thromb Vasc Biol Date: 2003-01-30 Impact factor: 8.311
Authors: Alberto Goday; David Benaiges; Alejandra Parri; José M Ramón; Juana A Flores-Le Roux; Juan Pedro Botet Journal: Surg Obes Relat Dis Date: 2014-05-02 Impact factor: 4.734
Authors: A Tschoner; W Sturm; C Gelsinger; C Ress; M Laimer; J Engl; E Laimer; G Mühlmann; R Mittermair; S Kaser; H Tilg; C F Ebenbichler Journal: Obesity (Silver Spring) Date: 2013-05-25 Impact factor: 5.002
Authors: Beatrice von Jeinsen; Ramachandran S Vasan; David D McManus; Gary F Mitchell; Susan Cheng; Vanessa Xanthakis Journal: PLoS One Date: 2020-12-10 Impact factor: 3.240